top of page
CURRENT FUNDING
NIH/NIAID R01AI143639 (DITTMANN)
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity
The goal of this project is to characterize the transcription factor ELF1 in conferring broad antiviral activity, in vitro and in vivo.
NIH//NIAID R21AI139374 (DITTMANN)
SERPINs as a novel family of innate antiviral molecules
The goal of this project is to identify novel members of the serine protease inhibitor family that are critical for virus restriction in a polarized human airway epithelium model.
G. HAROLD AND LEILA Y. MATHERS CHARITABLE FOUNDATION
Identification of novel therapeutics for COVID-19
The goal of this project is to identify and characterize novel antivirals for SARS-CoV-2 infections, using in vitro and in vivo models.
THE VILCEK FOUNDATION (VALERO-JIMENEZ)
Postdoctoral Fellowship
NIH/NIAID T32AI17647 (PRESCOTT)
Training grant
bottom of page